Pharma news
Americas
Biotech company Thermo Fisher Scientific has announced plans to acquire Brammer Bio, a viral vector manufacturer for gene and cell therapies, for $1.7 billion. 26 March 2019
Pharma
The Court of Justice of the European Union’s recent refusal to provide further guidance on the full scope of Neurim in a case involving supplementary protection certificates last week has left some big questions unanswered. 25 March 2019
Pharma
The Court of Justice of the European Union yesterday, March 21, handed down a supplementary protection certificate decision referred to it by the English High Court. 22 March 2019
Pharma
Seven new drugs are forecasted to achieve annual sales of $1 billion or more by 2023, according to a new report. 21 March 2019
Pharma
Allergan and the Saint Regis Mohawk Tribe have again urged the US Supreme Court to hear their closely-followed litigation on tribal sovereign immunity, following a submission from generic maker Mylan in the case. 20 March 2019
Pharma
The US Supreme Court will seek the advice of the country’s solicitor general after it agreed to hear an appeal in a dispute over whether a medical treatment is directed towards a natural law. 19 March 2019
Americas
Danish pharmaceutical company Novo Nordisk and generics maker Teva have reached a settlement in their US dispute over Victoza. 19 March 2019
Pharma
A district court must revisit its decision that one of Allergan’s patents is valid and was not infringed by a competitor. 18 March 2019
Americas
Supranational organisations such as the World Health Organization and the United Nations Development Program are promoting acts, policies and practices that prevent biopharmaceutical innovators from securing and maintaining patents. 18 March 2019
Pharma
Doctors’ handwriting poses a significant challenge to the registration of pharmaceutical trademarks, according to a senior counsel at German pharmaceutical company Bayer. 15 March 2019